Key Findings:  The authors conclude that while medicinal cannabis in pediatric patients diagnosed with ASD are often presented as positive the actual scientific evidence is limited.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Canada
Year of Pub:  2022
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Fletcher S, et al. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review. Child Care Health Dev. 2022; 48:33-44. doi: 10.1111/cch.12909
Authors:  Fletcher S, Pawliuk C, Ip A, Huh L, Rassekh SR, Oberlander TF, Siden H